A case report of H-syndrome from Baghdad Medical City treated with tocilizumab.

Awadh NI, Gorial FI, Hashim HT, Al-Obaidi AD, Al-Obaidi MN, AlNoori AH, Aljanabi WK

DOI: 10.1002/ccr3.6775
Published: 2022 Dec
Container: Clinical case reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ccr3.6775,
  title = {A case report of H-syndrome from Baghdad Medical City treated with tocilizumab.},
  author = {Awadh NI and Gorial FI and Hashim HT and Al-Obaidi AD and Al-Obaidi MN and AlNoori AH and Aljanabi WK},
  year = {2022},
  journal = {Clinical case reports},
  doi = {10.1002/ccr3.6775},
  url = {https://doi.org/10.1002/ccr3.6775}
}

RIS

TY  - JOUR
TI  - A case report of H-syndrome from Baghdad Medical City treated with tocilizumab.
AU  - Awadh NI
AU  - Gorial FI
AU  - Hashim HT
AU  - Al-Obaidi AD
AU  - Al-Obaidi MN
AU  - AlNoori AH
AU  - Aljanabi WK
PY  - 2022
JO  - Clinical case reports
DO  - 10.1002/ccr3.6775
UR  - https://doi.org/10.1002/ccr3.6775
ER  -

APA

NI, A., FI, G., HT, H., AD, A., MN, A., AH, A., & WK, A. (2022). A case report of H-syndrome from Baghdad Medical City treated with tocilizumab.. Clinical case reports. https://doi.org/10.1002/ccr3.6775

Source records

pubmed · retrieved 2026-09-26T18:48:30.107Z